Skip to main content

Closed

GNTA: Genenta Science S.p.A. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-21.3%

Financially safe

Stretched

Debt / equity0.35×

Interest coverage-17.0×

Current ratio14.16×

Genenta Science S.p.A.

GNTANASDAQ Capital Market·USD·Closed

Genenta Science S.p.A.

GNTANASDAQ·USD·Closed

$1.49

−1.32%

$1.49

−$0.02 (1.32%)

52W Range

10thpctl

Volume

0.02×avg

Mkt Cap

28.53MUSD

P/E

-3.9TTM

Div Yield

–ann

52W Range

10thpctl

Volume

0.02×avg

Market Cap

28.53MUSD

P/E Ratio

-3.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings